About us

A World Wide
CRO & CMO

Bellen Chemistry has been founded in 2007 by Dr Bob Liu, CEO.
Bellen is CRO & CMO company dedicated to heterocyclic chemistry, from grams to tons, to accompany customers’ projects at any stages of their R&D workflow, and for their first steps of manufacturing.

For years now, our customers choose to partner with Bellen because of our appreciated strengths:
1. Customer focus to meet tight timeline & urgent needs;
2. Special reagents/reaction safe handling (cyanide, diazonium, azide, BuLi, LAH, Dess-Martin, etc.);
3. Innovative route design and exploration to mitigate the process risk and shorten the supply timeline;
4. Process optimization based on the default screening scenarios;
5. New technologies in place or being built up in alignment with customer needs;
6. High productivity and, as a result better competitiveness for the defined tasks;
7. Transparent communication for the positive/negative results;
8. Process safety & quality considered as high priority within Bellen;
9. Rich experience for long steps complex molecules manufacture (e.g. > 18 steps);
10. Harworking teams

  • Bellen Chemistry's launch

    founded with 8 employees

  • 30 scientists

    2000 m² of general labs

  • Become a CRO Company

    100 scientists

    Revenue: 5M$

  • 160 scientists

    Move to a new lab :
    7000 m² of general and kilo-lab

    Revenue: 19M$

  • Double capacity of kilo-lab

    Pilot plant under construction

    Revenue: 35M$

  • Pilot plant in Shandong

    Become CRO & CMO Company

    Revenue: 42M$

  • Process R&D Center

    Opening of our new Process R&D Center in Shanghai.

    Revenue: 52M$

  • Phase II of Bellen's growth

    Double capacity of MedChem labs in Beijing, double capacity of Process R&D Center in Shanghai, start building 3 new pilot plants in Shandong.

Awards

Bellen
Group

Bellen grew up with Pharmaceutical Industries, using any audit as an opportunity to improve EHS, IP protection and to fit better with customers’ needs and expectations. As a result, Bellen has been awarded by several pharmaceutical companies.

350 employees are currently working for Bellen Group, sharing our values:

  • Customer centricity
  • Trust and honesty
  • Respect and Teamwork
  • Horizontal management
  • Timely rewards and recognition
  • Work life balance
Worldwide map Bellen Beijing - Headquarters
Beijing - Headquarters

Beijing - Headquarters

No.1, Caida 3rd Street, MaoHua Garden, ShunYi District, Beijing 101300, China

info@bellenchem.com

Shandong - Pilot plant

Shandong - Pilot plant

Dahuchenjia Village, Jinling Town, Zhaoyuan City, Shandong Province, China

qiang.ma@bellenchem.com

Shanghaï - R&D Center

Shanghaï - R&D Center

No.101 Room, No.2 Building, No.999 Jiangyue Road, Minhang District, Shanghai, China

bo.han@bellenchem.com

Bellen Europe SAS

Bellen Europe SAS

44 rue Boson, F-38200 Vienne, France

sales.europe@bellenchem.eu

Bellen Catalog Inc.

Bellen Catalog Inc.

23 Woodlawn Rd, Totonto, ON L3P 7G7, Canada

mike.xu@bellencatalog.com

Bellen US

Bellen US

970 Blair Ct, Palo Alto, CA 94303, USA

sales_us@bellenchem.com

Select a city to discover the contact details of our facilities.

Our
facilities

Nearly every month, we are glad to welcome our customers in one of our facilities, either for a formal audit, or just for a meeting. In both case, please reach out your local contact to arrange your visit ! We will be more than happy to show you our capabilities and introduce you to our teams.
In the meantime, you can have a preview by reading the webpages dedicated to our sites in : Beijing, Shanghai and Shandong.
Looking forward to meeting you there !

Bellen
Our team

Dr Bob Liu

Dr Bob Liu

CEO
Bellen Co. Ltd.

PhD in Organic Chemistry,
University of Tsinghua, Beijing, China

Bellen, a fast growing CRO/CMO company to supply the platform for the new drug discovery and process development, cooperated with Pharmaceutical companies and biotech companies since April, 2007, we haven’t pursued our own program for new drug discovery but aimed to cooperate our global clients to speed up their new drug discovery for the innovative new medicines. Combined with our strong expertise for heterocycles and know-how technology, customer-focus culture, Bellen has gaineda lot of appraisal from clients for the innovation of synthesis capability, fast delivery, good quality and technology-wise process research. Indeed, towards the direction of ‘ Your premier source for heterocycles’, a group of experienced scientists are welcoming your next opportunity for the cooperation to commit our efforts to improve people’s lives through new drug discovery.

Bellen’s flexible business model including Bellen Catalog (and requested catalog), custom-synthesis, process development and production departments are pursuing to supply the first-in-class art for the organic synthesis especially for heterocycles. FTE and flexible FTE models are accepted here to meet the different requests from the new drug discovery programs. Focused on heterocycles, Pursued Synthetic art, we are dreaming for the win-win cooperation.

Bob Liu Ph.D, CEO Bellen Co. Ltd.

Sales staff

Cecile has a scientific background (Master in Biochemistry and Master in Forensic Science from Lyon University, France).
She started her carrier in public research, working as research engineer for CNRS in analytical chemistry (doping control, food adulteration, etc.).
She joined later on Aventis CropScience (today Bayer CropScience) to support the launch of a brand new analytical platform dedicated to fungi and mycotoxines identification and quantification.
She then decided to move out of the labs and joined Sigma-Aldrich, first as technical service specialist. She has been promoted quickly to different positions within the Company, during the 12 years of collaboration, the last one being Sales Manager for the Pharmaceutical Research Business Unit.
Joining Bellen Chemistry in 2016, as a Sales & Marketing Director was a kind of achievement and a great opportunity to use plenty of different skills she has developped during the first part of her carrier.

Dr. Mike Xu, Vice President of Bellen group and General Manager of Bellen Catalog Inc.

Mike joined Bellen Chemistry Co., Ltd. in 2017. He has over 20 years of analytical R&D experience across petrochemical and pharmaceutical industries with a focus on analytical R&D /QC in cGMP regulated pharma organizations (Apotex, Frontage and Novartis).

Prior to joining Bellen group, he worked in Novartis China for 10 years and served as head of analytical R&D, senior operation manager and global project leader in process and analytical R&D for drug substance development. He has enriched expertise and experience with impurity control. He has led a great number of projects in the process R&D and manufacturing to supply drug substance for pre /clinical studies throughout drug development roadmap from candidate selection to clinical batch campaigns.

Mike received his Ph.D. in analytical chemistry from Research Institute of Sinopec and he also received a M.Sc. in analytical chemistry from University of Waterloo and a M.Sc. in physical chemistry from Tsinghua University.

mike.xu@bellencatalog.com

20+ years of experience in Lab Supply, Logistics and Industrial market.
David worked during 20 years for Sigma-Aldrich in France, firstly in the logistics department, taking care of custom clearance, contract with carriers, purchasing.
Based on his experience, he built the first outsourcing service within Sigma-Aldrich, in order to offer to customers what they didn’t find in the catalogs.
One of the first supplier and the most reliable one at this time already was Bellen Chemistry.
When Bob Liu, CEO of Bellen Chemistry, planned his development in Europe, he was looking for a reliable partner to manage this project with him, and immediately felt that David could be this guy !

20+ years of experience in MedChem at Abbott, Amgen. Co-inventor of Lopinavir/ Ritonavir

Scientists

Cecile has a scientific background (Master in Biochemistry and Master in Forensic Science from Lyon University, France).
She started her carrier in public research, working as research engineer for CNRS in analytical chemistry (doping control, food adulteration, etc.).
She joined later on Aventis CropScience (today Bayer CropScience) to support the launch of a brand new analytical platform dedicated to fungi and mycotoxines identification and quantification.
She then decided to move out of the labs and joined Sigma-Aldrich, first as technical service specialist. She has been promoted quickly to different positions within the Company, during the 12 years of collaboration, the last one being Sales Manager for the Pharmaceutical Research Business Unit.
Joining Bellen Chemistry in 2016, as a Sales & Marketing Director was a kind of achievement and a great opportunity to use plenty of different skills she has developped during the first part of her carrier.

Dr. Mike Xu, Vice President of Bellen group and General Manager of Bellen Catalog Inc.

Mike joined Bellen Chemistry Co., Ltd. in 2017. He has over 20 years of analytical R&D experience across petrochemical and pharmaceutical industries with a focus on analytical R&D /QC in cGMP regulated pharma organizations (Apotex, Frontage and Novartis).

Prior to joining Bellen group, he worked in Novartis China for 10 years and served as head of analytical R&D, senior operation manager and global project leader in process and analytical R&D for drug substance development. He has enriched expertise and experience with impurity control. He has led a great number of projects in the process R&D and manufacturing to supply drug substance for pre /clinical studies throughout drug development roadmap from candidate selection to clinical batch campaigns.

Mike received his Ph.D. in analytical chemistry from Research Institute of Sinopec and he also received a M.Sc. in analytical chemistry from University of Waterloo and a M.Sc. in physical chemistry from Tsinghua University.

mike.xu@bellencatalog.com

20+ years of experience in Lab Supply, Logistics and Industrial market.
David worked during 20 years for Sigma-Aldrich in France, firstly in the logistics department, taking care of custom clearance, contract with carriers, purchasing.
Based on his experience, he built the first outsourcing service within Sigma-Aldrich, in order to offer to customers what they didn’t find in the catalogs.
One of the first supplier and the most reliable one at this time already was Bellen Chemistry.
When Bob Liu, CEO of Bellen Chemistry, planned his development in Europe, he was looking for a reliable partner to manage this project with him, and immediately felt that David could be this guy !

20+ years of experience in MedChem at Abbott, Amgen. Co-inventor of Lopinavir/ Ritonavir

  • You talk about Bellen

    My Company has been working with Bellen for more than 3 years on more than 100 projects.
    We are very happy with Bellen’s services. Bellen is fast to provide quotes, very competitive price, easy to communicate, willing to try suggestions, on-time delivery, and in good quality.

    W.L.

  • You talk about Bellen

    As a company developing small molecule therapeutics, we have been outsourcing most of our chemistry work. I got to know Bellen Chemistry through referral from a friend. After subsequent meeting with Dr. Charles Chen, a Bellen representative in the US, I was very impressed not only by the company’s expertise and capability, but also by its flexibility of working with its customers. I decided to give a try initially with a few compounds of small quantity. Dr. Jack Su and his team did an excellent job. We were very satisfied with the timely delivery and the quality of products.

    Like other companies in the pharmaceutical industry, we are concerned about a potential compromise in IP protection with outsourcing. A confidentiality agreement may not be sufficient to prevent plagiarism from happening, which was the case seen before with some full service CROs. We had a candid discussion with Bellen’s founder Dr. Bob Liu and his team, and learned that the confined business scope of Bellen gave them no incentive nor ability to infringe IPs, because the company’s business is limited only to chemical synthesis, without touching other areas in the drug development.

    We have been expanding our contract with Bellen since 2016. It has been a very pleasant experience working with Bellen. The company provides not only competitive pricing, but also high quality of services. The people at Bellen are honest, responsible and highly talented. They have never failed to deliver what they promised us, for our orders with scales from less than 1 gram to larger than 10 kilograms. Our most recent large scale order of a compound (17.5kg) required the optimization of synthetic route and the development of in-process control and analytical methods. Thanks to Dr. Bo Han and his team, their expertise and dedicated work enabled the manufacture of our compounds with reliable processes as well as reduced costs.

    R.C. - Aluda